Search

Samuel A. Acquah

Examiner (ID: 3913)

Most Active Art Unit
1711
Art Unit(s)
1503, 1711, 1774, 2899, 1207, 1754
Total Applications
2690
Issued Applications
2329
Pending Applications
91
Abandoned Applications
269

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19098149 [patent_doc_number] => 20240117377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN GABAERGIC NEURONS AND ASTROCYTES [patent_app_type] => utility [patent_app_number] => 18/263930 [patent_app_country] => US [patent_app_date] => 2022-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23664 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -68 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263930 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/263930
ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN GABAERGIC NEURONS AND ASTROCYTES Feb 1, 2022 Pending
Array ( [id] => 17593522 [patent_doc_number] => 20220143095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => NOVEL ANUCLEATED CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/581329 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34509 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581329 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/581329
NOVEL ANUCLEATED CELLS AND USES THEREOF Jan 20, 2022 Abandoned
Array ( [id] => 17828420 [patent_doc_number] => 20220265724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => CELL THERAPEUTIC AGENT FOR ANTI-INFLAMMATORY OR DAMAGED TISSUE REGENERATION COMPRISING PRUSSIAN BLUE NANOPARTICLES, AND METHOD FOR PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 17/571116 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8853 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571116 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/571116
CELL THERAPEUTIC AGENT FOR ANTI-INFLAMMATORY OR DAMAGED TISSUE REGENERATION COMPRISING PRUSSIAN BLUE NANOPARTICLES, AND METHOD FOR PREPARING THE SAME Jan 6, 2022 Pending
Array ( [id] => 17532373 [patent_doc_number] => 20220110982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => MAPC TREATMENT OF BRAIN INJURIES AND DISEASES [patent_app_type] => utility [patent_app_number] => 17/556330 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556330 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/556330
MAPC TREATMENT OF BRAIN INJURIES AND DISEASES Dec 19, 2021 Abandoned
Array ( [id] => 17546685 [patent_doc_number] => 20220118026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => MAPC TREATMENT OF BRAIN INJURIES AND DISEASES [patent_app_type] => utility [patent_app_number] => 17/556380 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18586 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556380 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/556380
MAPC TREATMENT OF BRAIN INJURIES AND DISEASES Dec 19, 2021 Abandoned
Array ( [id] => 19049298 [patent_doc_number] => 20240091267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => PRE-TREATMENT OF MSC WITH PPARB/DELTA AGONIST FOR TREATMENT OF ISCHEMIA-REPERFUSION INJURY [patent_app_type] => utility [patent_app_number] => 18/267957 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19919 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267957 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/267957
PRE-TREATMENT OF MSC WITH PPARB/DELTA AGONIST FOR TREATMENT OF ISCHEMIA-REPERFUSION INJURY Dec 16, 2021 Pending
Array ( [id] => 17519308 [patent_doc_number] => 20220105156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => METHODS OF TREATMENT FOR KIDNEY DISEASE [patent_app_type] => utility [patent_app_number] => 17/644244 [patent_app_country] => US [patent_app_date] => 2021-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644244 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/644244
METHODS OF TREATMENT FOR KIDNEY DISEASE Dec 13, 2021 Pending
Array ( [id] => 18879419 [patent_doc_number] => 20240002788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => Regenerative Tissue Extract from Non-Human Mammalian Placenta [patent_app_type] => utility [patent_app_number] => 18/039372 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5917 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039372 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/039372
Regenerative Tissue Extract from Non-Human Mammalian Placenta Dec 2, 2021 Pending
Array ( [id] => 19049303 [patent_doc_number] => 20240091272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => ENGINEERED MULTICELLULAR ORGANISMS [patent_app_type] => utility [patent_app_number] => 18/254929 [patent_app_country] => US [patent_app_date] => 2021-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5770 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254929 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/254929
ENGINEERED MULTICELLULAR ORGANISMS Nov 29, 2021 Pending
Array ( [id] => 18893764 [patent_doc_number] => 20240009249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => ADIPOGENIC CELL COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 18/038630 [patent_app_country] => US [patent_app_date] => 2021-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43150 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038630 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/038630
ADIPOGENIC CELL COMPOSITIONS AND METHODS Nov 23, 2021 Pending
Array ( [id] => 17458742 [patent_doc_number] => 20220072046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS [patent_app_type] => utility [patent_app_number] => 17/534513 [patent_app_country] => US [patent_app_date] => 2021-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534513 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/534513
MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS Nov 23, 2021 Pending
Array ( [id] => 19081861 [patent_doc_number] => 20240108662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/039387 [patent_app_country] => US [patent_app_date] => 2021-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -71 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039387 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/039387
ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF Nov 22, 2021 Pending
Array ( [id] => 17444088 [patent_doc_number] => 20220064593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHODS RELATING TO PLURIPOTENT CELLS [patent_app_type] => utility [patent_app_number] => 17/526885 [patent_app_country] => US [patent_app_date] => 2021-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31948 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526885 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/526885
METHODS RELATING TO PLURIPOTENT CELLS Nov 14, 2021 Pending
Array ( [id] => 17867372 [patent_doc_number] => 20220290108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM [patent_app_type] => utility [patent_app_number] => 17/510717 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4978 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17510717 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/510717
OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM Oct 25, 2021 Abandoned
Array ( [id] => 18511616 [patent_doc_number] => 20230227786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => PREPARATION METHOD AND RECOVERY METHOD OF PARIDUVAL MESENCHYMAL STEM CELLS (PMSCs) [patent_app_type] => utility [patent_app_number] => 18/009473 [patent_app_country] => US [patent_app_date] => 2021-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5693 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009473 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/009473
PREPARATION METHOD AND RECOVERY METHOD OF PARIDUVAL MESENCHYMAL STEM CELLS (PMSCs) Oct 21, 2021 Pending
Array ( [id] => 17383905 [patent_doc_number] => 20220031757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => METHOD FOR REPAIRING DAMAGED TISSUE [patent_app_type] => utility [patent_app_number] => 17/503756 [patent_app_country] => US [patent_app_date] => 2021-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503756 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/503756
METHOD FOR REPAIRING DAMAGED TISSUE Oct 17, 2021 Abandoned
Array ( [id] => 17519397 [patent_doc_number] => 20220105245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => BONE-LIKE PROSTHETIC IMPLANTS [patent_app_type] => utility [patent_app_number] => 17/500341 [patent_app_country] => US [patent_app_date] => 2021-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13459 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500341 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/500341
BONE-LIKE PROSTHETIC IMPLANTS Oct 12, 2021 Abandoned
Array ( [id] => 17370279 [patent_doc_number] => 20220025331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => METHODS AND SYSTEMS FOR IMPROVING CELLS FOR USE IN THERAPY [patent_app_type] => utility [patent_app_number] => 17/496391 [patent_app_country] => US [patent_app_date] => 2021-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496391 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/496391
METHODS AND SYSTEMS FOR IMPROVING CELLS FOR USE IN THERAPY Oct 6, 2021 Pending
Array ( [id] => 19186253 [patent_doc_number] => 20240165166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE [patent_app_type] => utility [patent_app_number] => 18/043064 [patent_app_country] => US [patent_app_date] => 2021-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45210 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043064 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/043064
PRIMED PLACENTAL TISSUE AND USES IN REGENERATIVE MEDICINE Sep 29, 2021 Pending
Array ( [id] => 18771123 [patent_doc_number] => 20230365933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => COMPOSITIONS AND METHODS FOR INCREASING STEM CELL FUNCTION [patent_app_type] => utility [patent_app_number] => 18/246710 [patent_app_country] => US [patent_app_date] => 2021-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9711 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246710 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/246710
COMPOSITIONS AND METHODS FOR INCREASING STEM CELL FUNCTION Sep 27, 2021 Pending
Menu